Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
HitIQ Limited ( (AU:HIQ) ) just unveiled an update.
HITIQ Limited has been awarded a prestigious grant from the Australian Sports Commission under ‘The Park’ innovation programme, which supports cutting-edge sports technology development. This grant will enable HITIQ to further develop and validate their PROTEQT™ technology within elite sporting environments, enhancing their market credibility and positioning them as a leader in athlete brain health protection across Australian sports. The initiative will also facilitate the adoption of their technology by National Sporting Organisations, Olympic and Paralympic sports, and community sports, contributing to the development of national safety standards and evidence-based policies for brain health.
The most recent analyst rating on (AU:HIQ) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
More about HitIQ Limited
HITIQ Limited operates in the sports technology industry, focusing on head impact detection, concussion management, and athlete brain health monitoring solutions. Their primary product, PROTEQT™, is designed to improve athlete safety and wellbeing by providing advanced sensor capabilities and data analytics for brain health monitoring.
Average Trading Volume: 653,781
Technical Sentiment Signal: Buy
Current Market Cap: A$12.67M
See more data about HIQ stock on TipRanks’ Stock Analysis page.